101 related articles for article (PubMed ID: 33892274)
1. An innovative fluorescent probe targeting IGF1R for breast cancer diagnosis.
Xu H; Zhao Y; Gao X; Wang F; Gu Y
Eur J Med Chem; 2021 Jul; 219():113440. PubMed ID: 33892274
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent tumour imaging of type I IGF receptor in vivo: comparison of antibody-conjugated quantum dots and small-molecule fluorophore.
Zhang H; Zeng X; Li Q; Gaillard-Kelly M; Wagner CR; Yee D
Br J Cancer; 2009 Jul; 101(1):71-9. PubMed ID: 19491901
[TBL] [Abstract][Full Text] [Related]
3. Multi-modal imaging probe for EpCAM overexpressed in breast cancer.
Dai Y; Tang Y; Huang W; Zhao Y; Gao X; Gu Y
Talanta; 2022 Dec; 250():123715. PubMed ID: 35868149
[TBL] [Abstract][Full Text] [Related]
4. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
5. Based on lapatinib innovative near-infrared fluorescent probes targeting HER1/HER2 for in vivo tumors imaging.
Li C; Lin Q; Hu F; Bao R; Cai H; Gu Y
Biosens Bioelectron; 2022 Oct; 214():114503. PubMed ID: 35779413
[TBL] [Abstract][Full Text] [Related]
6. ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway.
Tognon CE; Somasiri AM; Evdokimova VE; Trigo G; Uy EE; Melnyk N; Carboni JM; Gottardis MM; Roskelley CD; Pollak M; Sorensen PH
Cancer Res; 2011 Feb; 71(3):1060-70. PubMed ID: 21148487
[TBL] [Abstract][Full Text] [Related]
7. CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy.
Rostoker R; Ben-Shmuel S; Rashed R; Shen Orr Z; LeRoith D
Breast Cancer Res; 2016 May; 18(1):51. PubMed ID: 27179633
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-1 receptor gene expression is associated with survival in breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression.
Fu P; Ibusuki M; Yamamoto Y; Hayashi M; Murakami K; Zheng S; Iwase H
Breast Cancer Res Treat; 2011 Nov; 130(1):307-17. PubMed ID: 21748295
[TBL] [Abstract][Full Text] [Related]
10. Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells.
Sarfstein R; Nagaraj K; LeRoith D; Werner H
Cells; 2019 Nov; 8(12):. PubMed ID: 31771180
[TBL] [Abstract][Full Text] [Related]
11. A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells.
Sachdev D; Hartell JS; Lee AV; Zhang X; Yee D
J Biol Chem; 2004 Feb; 279(6):5017-24. PubMed ID: 14615489
[TBL] [Abstract][Full Text] [Related]
12. The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study.
Jaillardon L; Abadie J; Godard T; Campone M; Loussouarn D; Siliart B; Nguyen F
BMC Cancer; 2015 Oct; 15():664. PubMed ID: 26449867
[TBL] [Abstract][Full Text] [Related]
13. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
[TBL] [Abstract][Full Text] [Related]
14. Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative.
Chakravarti B; Siddiqui JA; Dwivedi SK; Deshpande S; Samanta K; Bhatta RS; Panda G; Prabhakar YS; Konwar R; Sanyal S; Chattopadhyay N
Mol Cell Endocrinol; 2011 May; 338(1-2):68-78. PubMed ID: 21457754
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
Zhang H; Pelzer AM; Kiang DT; Yee D
Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Influence of Different Albumin Binders on Molecular Imaging Probe Distribution.
Höltke C; Grewer M; Stölting M; Geyer C; Wildgruber M; Helfen A
Mol Pharm; 2021 Jul; 18(7):2574-2585. PubMed ID: 34048242
[TBL] [Abstract][Full Text] [Related]
17. IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors.
Evdokimova V; Tognon CE; Benatar T; Yang W; Krutikov K; Pollak M; Sorensen PH; Seth A
Sci Signal; 2012 Dec; 5(255):ra92. PubMed ID: 23250396
[TBL] [Abstract][Full Text] [Related]
18. Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer.
Tamimi RM; Colditz GA; Wang Y; Collins LC; Hu R; Rosner B; Irie HY; Connolly JL; Schnitt SJ
Breast Cancer Res Treat; 2011 Jul; 128(1):243-50. PubMed ID: 21197570
[TBL] [Abstract][Full Text] [Related]
19. Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma.
Hartog H; Horlings HM; van der Vegt B; Kreike B; Ajouaou A; van de Vijver MJ; Marike Boezen H; de Bock GH; van der Graaf WT; Wesseling J
Breast Cancer Res Treat; 2011 Oct; 129(3):725-36. PubMed ID: 21107683
[TBL] [Abstract][Full Text] [Related]
20. Theranostic imaging of liver cancer using targeted optical/MRI dual-modal probes.
Chen Q; Shang W; Zeng C; Wang K; Liang X; Chi C; Liang X; Yang J; Fang C; Tian J
Oncotarget; 2017 May; 8(20):32741-32751. PubMed ID: 28416757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
